IAIM
CRL icon

International Assets Investment Management’s Charles River Laboratories CRL Stock Holding History

International Assets Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-216
Closed -$42.5K – 1041
2024
Q3 		$42.5K Buy
+216
New +$44.9K ﹤0.01% 1119
2022
Q1 		– Sell
-544
Closed -$205K – 504
2021
Q4 		$205K Buy
+544
New +$211K 0.04% 458
2021
Q2 		– Sell
-80
Closed -$20K – 783
2021
Q1 		$20K Hold
80
– – ﹤0.01% 1296
2020
Q4 		$20K Buy
+80
New +$19.1K ﹤0.01% 1159

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

International Assets Investment Management's CRL Position: Q4 2024 in Review

International Assets Investment Management sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 216 shares — an estimated $42.5K sold.

International Assets Investment Management first reported a position in CRL in Q4 2020 and held it in 4 quarters. The position peaked at $205K in Q4 2021. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • International Assets Investment Management reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 216 Charles River Laboratories shares in Q4 2024, an estimated $42.5K.
  • International Assets Investment Management first reported a position in Charles River Laboratories in Q4 2020 and held it in 4 quarters.
  • International Assets Investment Management's Charles River Laboratories position peaked at $205K in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.